Role of HOXB7 in regulation of progression and metastasis of human lung adenocarcinoma

Molecular Carcinogenesis

Volumn 53, Issue 1, 2014, Pages 49-57

  Yuan, Weiwei ^a,b   Zhang, Xuelin ^a   Xu, Yu ^a   Li, Shasha ^a   Hu, Yide ^a   Wu, Shiyong ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b OHIO UNIVERSITY   (United States)

Author keywords

Clinical outcomes; HOXB7; Lung adenocarcinoma; Metastasis; Proliferation

Indexed keywords

FIBRONECTIN; HOMEODOMAIN PROTEIN; KI 67 ANTIGEN; LENTIVIRUS VECTOR; PROTEIN HOMEOBOX B7; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ADULT; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CARCINOGENICITY; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CLONOGENIC ASSAY; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS EPITHELIUM; LUNG CARCINOGENESIS; MALE; METASTASIS; METASTASIS POTENTIAL; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84890428074     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.21947     Document Type: Article

References (31)

1. Goldstraw P, Ball D, Jett JR, et al. Non-small-cell lung cancer. Lancet 2011; 378:1727-1740.
2. Tsim S, O'Dowd CA, Milroy R, Davidson S. Staging of non-small cell lung cancer (NSCLC): A review. Respir Med 2010; 104:1767-1774.
3. Sangodkar J, Katz S, Melville H, Narla G. Lung adenocarcinoma: Lessons in translation from bench to bedside. Mt Sinai J Med 2010; 77:597-605.
4. Moran C. Importance of molecular features of non-small cell lung cancer for choice of treatment. Am J Pathol 2011; 178:1940-1948.
5. Gettinger S. Targeted therapy in advanced non-small-cell lung cancer. Semin Respir Crit Care Med 2008; 29:291-301.
6. Lam KC, Mok TS. Targeted therapy: An evolving world of lung cancer. Respirology 2011; 16:13-21.
7. Azuma K, Nakagawa K. Molecular targeted therapy in lung cancer. Nihon Rinsho 2010; 68:1848-1853.
8. Liao WT, Jiang D, Yuan J, et al. HOXB7 as a prognostic factor and mediator of colorectal cancer progression. Clin Cancer Res 2011; 17:3569-3578.
9. Bitu CC, Carrera M, Lopes MA, Kowalski LP, Soares FA, Coletta RD. HOXB7 expression is a prognostic factor for oral squamous cell carcinoma. Histopathology 2012; 60:662-665.
10. Storti P, Donofrio G, Colla S, et al. HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients. Leukemia 2011; 25:527-537.
11. Agnelli L, Storti P, Todoerti K, et al. Overexpression of HOXB7 and homeobox genes characterizes multiple myeloma patients lacking the major primary immunoglobulin heavy chain locus translocations. Am J Hematol 2011; 86:E64-E66.
12. Svingen T, Tonissen KF. Altered HOX gene expression in human skin and breast cancer cells. Cancer Biol Ther 2003; 2:518-523.
13. Wu X, Chen H, Parker B, et al. HOXB7, a homeodomain protein, is overexpressed in breast cancer and confers epithelial-mesenchymal transition. Cancer Res 2006; 66:9527-9534.
14. Makiyama K, Hamada J, Takada M, et al. Aberrant expression of HOX genes in human invasive breast carcinoma. Oncol Rep 2005; 13:673-679.
15. Tschopp P, Duboule D. A genetic approach to the transcriptional regulation of Hox gene clusters. Annu Rev Genet 2011; 45:145-166.
16. Barber BA, Rastegar M. Epigenetic control of Hox genes during neurogenesis, development, and disease. Ann Anat 2010; 192:261-274.
17. Iimura T, Pourquie O. Hox genes in time and space during vertebrate body formation. Dev Growth Differ 2007; 49:265-275.
18. Foronda D, de Navas LF, Garaulet DL, Sanchez-Herrero E. Function and specificity of Hox genes. Int J Dev Biol 2009; 53:1404-1419.
19. Hombria JC, Lovegrove B. Beyond homeosis-HOX function in morphogenesis and organogenesis. Differentiation 2003; 71:461-476.
20. Wellik DM. Hox genes and kidney development. Pediatr Nephrol 2011; 26:1559-1565.
21. Shah N, Sukumar S. The Hox genes and their roles in oncogenesis. Nat Rev Cancer 2010; 10:361-371.
22. Yamabuki T, Takano A, Hayama S, et al. Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas. Cancer Res 2007; 67:2517-2525.
23. Abate-Shen C. Deregulated homeobox gene expression in cancer: Cause or consequence? Nat Rev Cancer 2002; 2:777-785.
24. Samuel S, Naora H. Homeobox gene expression in cancer: Insights from developmental regulation and deregulation. Eur J Cancer 2005; 41:2428-2437.
25. Cantile M, Franco R, Schiavo G, et al. The HOX genes network in uro-genital cancers: Mechanisms and potential therapeutic implications. Curr Med Chem 2011; 18:4872-4884.
26. Cillo C, Schiavo G, Cantile M, et al. The HOX gene network in hepatocellular carcinoma. Int J Cancer 2011; 129:2577-2587.
27. Kanai M, Hamada J, Takada M, et al. Aberrant expressions of HOX genes in colorectal and hepatocellular carcinomas. Oncol Rep 2010; 23:843-851.
28. Chen H, Lee JS, Liang X, et al. Hoxb7 inhibits transgenic HER-2/neu-induced mouse mammary tumor onset but promotes progression and lung metastasis. Cancer Res 2008; 68:3637-3644.
29. De Souza Setubal Destro MF, Bitu CC, Zecchin KG, et al. Overexpression of HOXB7 homeobox gene in oral cancer induces cellular proliferation and is associated with poor prognosis. Int J Oncol 2010; 36:141-149.
30. Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011; 6:244-285.
31. Kerr KM, Galler JS, Hagen JA, Laird PW, Laird-Offringa IA. The role of DNA methylation in the development and progression of lung adenocarcinoma. Dis Markers 2007; 23:5-30.